Glucosamine sulfate: the first clinical proven disease modifying drug for osteoarthritis / 中国新药与临床杂志
Chinese Journal of New Drugs and Clinical Remedies
; (12): 253-262, 2005.
Article
em Zh
| WPRIM
| ID: wpr-409883
Biblioteca responsável:
WPRO
ABSTRACT
The publish summarized three latest systemic reviews and given details of the landmark trail on glucosamine sulfate introduce the yesterday, today and a good future of disease modifying drug for osteoarthritis (DMOAD) on a view. It will helpful to promote the clinical, the assessment and the developing of DMOAD in China.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of New Drugs and Clinical Remedies
Ano de publicação:
2005
Tipo de documento:
Article